HC Wainwright reaffirmed their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $12.00 price objective on the stock. HC Wainwright also issued estimates for Anixa Biosciences’ FY2025 earnings at ($0.40) EPS. Anixa Biosciences Price Performance […]
HC Wainwright reissued their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a report issued on Thursday morning, Benzinga reports. The brokerage currently has a $12.00 target price on the stock. Anixa Biosciences Price Performance Shares of Anixa Biosciences stock opened at $4.08 on Thursday. Anixa Biosciences has a fifty-two week […]
HC Wainwright reissued their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research note released on Tuesday, Benzinga reports. They currently have a $12.00 target price on the stock. Separately, TheStreet lowered Anixa Biosciences from a c- rating to a d rating in a research note on Friday, June 16th. […]
Anixa Biosciences, Inc. (NASDAQ:ANIX – Get Free Report) was the recipient of a significant decline in short interest in July. As of July 31st, there was short interest totalling 663,000 shares, a decline of 6.0% from the July 15th total of 705,300 shares. Based on an average daily volume of 88,000 shares, the days-to-cover ratio […]
HC Wainwright reissued their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research report report published on Friday morning, Benzinga reports. They currently have a $12.00 price target on the stock. Separately, TheStreet cut shares of Anixa Biosciences from a c- rating to a d rating in a research note […]